Streetbeat News

Products Services

MRK

MRNA

MYNZ

PFE

Pfizer and Moderna are leveraging mRNA technology, initially successful in COVID-19 vaccines, to target cancer treatment. Pfizer is focusing on oncology with a $43 billion acquisition of Seagen, while Moderna collaborates with Merck on cancer trials. Mainz Biomed is advancing early cancer detection with its ColoAlert test.

Portfolio Pulse from Upwallstreet

October 01, 2024 | 6:11 pm

MSFT

TWLO

Twilio has announced an integration with OpenAI's Realtime API, allowing its vast customer base and developers to create conversational AI voice experiences using GPT-4o.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 6:11 pm

AAPL

Apple Inc. (NASDAQ:AAPL) continues its tradition of displaying the time as 9:41 on its devices during product launches, a practice dating back to Steve Jobs. The recent 'Glowtime' event introduced the iPhone 16 series, Apple Watch Series 10, and AirPods 4, focusing on new AI features.

Portfolio Pulse from Adam Eckert

October 01, 2024 | 6:08 pm

QQQ

SQQQ

ProShares UltraPro Short QQQ (SQQQ) ETF rose 5% amid reports of Iran launching a missile attack against Israel, escalating geopolitical tensions. SQQQ, an inverse ETF of the Nasdaq-100, benefits from declines in tech-heavy stocks, making it attractive during market volatility.

Portfolio Pulse from Henry Khederian

October 01, 2024 | 5:58 pm

GOOG

GOOGL

TCEHY

Epic Games has introduced Time Limit Controls in Fortnite, allowing parents to manage their children's playtime. This update addresses previous criticisms about in-game purchases and lack of parental controls. Epic Games, backed by Tencent Holdings, aims to align with parental and regulatory demands.

Portfolio Pulse from Franca Quarneti

October 01, 2024 | 5:56 pm

GRTS

Gritstone Bio Inc. (NASDAQ:GRTS) released interim Phase 2 data for its GRANITE immunotherapy, showing some benefits in low-risk colorectal cancer patients. However, JMP Securities downgraded the stock due to insufficient excitement among investors. Gritstone has hired Raymond James to evaluate options.

Portfolio Pulse from Vandana Singh

October 01, 2024 | 5:55 pm

JNJ

Johnson & Johnson plans to invest over $2 billion in a new advanced technology manufacturing facility in North Carolina. This investment aims to support the company's portfolio growth.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 5:54 pm

DIA

GLD

QQQ

SPY

USO

Iran launched a missile attack on Israel, escalating Middle East tensions. This has led to a rise in oil and gold prices, while the S&P 500, Dow Jones, Nasdaq, and Bitcoin have fallen. The US is increasing its military presence in the region.

Portfolio Pulse from Chris Katje

October 01, 2024 | 5:51 pm

Toyota Motor Corporation reported a significant drop in U.S. sales for September, with a 20.3% decline in volume. However, nearly 50% of sales were electrified vehicles, marking a 22.4% increase in this segment. Despite the overall sales drop, Toyota remains the top retail brand, and Lexus achieved its best-ever year-to-date sales.

Portfolio Pulse from Nabaparna Bhattacharya

October 01, 2024 | 5:42 pm

TEVA

Teva Pharmaceutical Industries has launched the first generic version of Sandostatin LAR Depot in the U.S., targeting conditions like acromegaly and carcinoid syndrome. This move is expected to offer a more affordable treatment option, with the brand-name drug having annual sales of $826 million. Despite this positive development, Teva's stock is down 2.6%, potentially influenced by geopolitical tensions involving Israel.

Portfolio Pulse from Vaishali Prayag

October 01, 2024 | 5:42 pm